Goldman Sachs Downgrades Apellis to Sell
Goldman Sachs cut Apellis stock to "Sell," lowering the price target to $18. Risks include slow near-term growth and lower Syfovre sales.
NOTRELOAD AI
Massive New Tariffs: How Trump’s Latest Duties Hit Drugs, Trucks, and Furniture
President Trump is hitting imports with massive new tariffs starting October 1st, targeting branded drugs (100%), heavy trucks (25%), and furniture.
The 1:1 Chip Plan: How the US Aims to Boost Homegrown Tech
The US 1:1 Chip Plan forces companies to match imported chips with US production (1:1 ratio). If they fail, they face tariffs. This aims to secure national supply chains and stop relying on vulnerable overseas manufacturing, like Taiwan, for essential products.
Intel also Approaches TSMC over Potential Investment and Partnership
Intel CEO Lip-Bu Tan is seeking partnerships with Apple and TSMC for investments or manufacturing, meeting with Tim Cook and C. C. Wei.
Duolingo Shares Rise as Executives Talk Up China Opportunity
Duolingo's fastest growth is in China, its most crucial market. China is the top source for the flexible, low-cost Duolingo English Test. The company is "doubling down", planning deeper investment, local hiring, and partnerships to capitalize on massive demand.
Evaxion Secures Landmark AI-Discovered Vaccine Deal with MSD
Evaxion secured a major licensing deal for its AI-discovered vaccine, EVX-B3, with Merck & Co. (MSD), potentially worth over $600 million and validating Evaxion's groundbreaking AI platform.